🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 16 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/04/1982 | 2,02 | 2,03 | 2,01 | 2,03 | +0,50% | 0,98% | 2.935.238 |
| 29/04/1982 | 2,01 | 2,02 | 2,00 | 2,02 | -0,82% | 1,15% | 4.610.362 |
| 28/04/1982 | 2,04 | 2,05 | 2,02 | 2,03 | -0,65% | 1,47% | 3.437.021 |
| 27/04/1982 | 2,05 | 2,07 | 2,03 | 2,05 | -0,80% | 1,94% | 2.508.912 |
| 26/04/1982 | 2,06 | 2,07 | 2,05 | 2,06 | -0,16% | 1,12% | 2.599.459 |
| 23/04/1982 | 2,05 | 2,07 | 2,02 | 2,07 | +2,12% | 2,10% | 4.576.406 |
| 22/04/1982 | 2,02 | 2,03 | 2,01 | 2,02 | -0,16% | 1,31% | 4.848.048 |
| 21/04/1982 | 2,02 | 2,03 | 2,00 | 2,03 | +0,83% | 1,80% | 3.214.426 |
| 20/04/1982 | 2,01 | 2,03 | 1,99 | 2,01 | +1,50% | 1,98% | 3.795.437 |
| 19/04/1982 | 1,99 | 2,01 | 1,97 | 1,98 | +0,51% | 2,16% | 5.538.470 |
| 16/04/1982 | 1,95 | 1,98 | 1,92 | 1,97 | +3,30% | 2,88% | 11.880.547 |
| 15/04/1982 | 1,92 | 1,92 | 1,91 | 1,91 | -0,52% | 0,69% | 3.999.168 |
| 14/04/1982 | 1,92 | 1,94 | 1,90 | 1,92 | -1,70% | 2,24% | 3.244.608 |
| 13/04/1982 | 1,96 | 1,97 | 1,95 | 1,95 | -1,99% | 1,35% | 2.369.318 |
| 12/04/1982 | 1,98 | 1,99 | 1,97 | 1,99 | +0,17% | 1,00% | 2.350.454 |
| 08/04/1982 | 1,99 | 1,99 | 1,98 | 1,99 | +0,33% | 0,83% | 4.074.624 |
| 07/04/1982 | 1,99 | 2,00 | 1,98 | 1,98 | +0,00% | 1,17% | 2.705.098 |
| 06/04/1982 | 1,97 | 1,98 | 1,95 | 1,98 | +0,33% | 1,85% | 2.214.634 |
| 05/04/1982 | 1,98 | 1,98 | 1,97 | 1,97 | -0,33% | 0,50% | 1.912.810 |
| 02/04/1982 | 1,96 | 1,98 | 1,95 | 1,98 | +2,05% | 1,68% | 4.931.050 |
| 01/04/1982 | 1,93 | 1,94 | 1,91 | 1,94 | +1,56% | 1,55% | 3.297.427 |
| 31/03/1982 | 1,91 | 1,92 | 1,90 | 1,91 | +0,52% | 1,04% | 2.999.376 |
| 30/03/1982 | 1,90 | 1,91 | 1,88 | 1,90 | +0,17% | 1,57% | 3.531.341 |
| 29/03/1982 | 1,91 | 1,92 | 1,89 | 1,90 | -1,03% | 1,57% | 1.618.531 |
| 26/03/1982 | 1,93 | 1,94 | 1,92 | 1,92 | -2,20% | 1,37% | 2.222.179 |
| 25/03/1982 | 1,96 | 1,97 | 1,95 | 1,96 | -0,67% | 1,18% | 5.217.782 |
| 24/03/1982 | 1,98 | 1,99 | 1,97 | 1,97 | -0,33% | 1,01% | 2.806.963 |
| 23/03/1982 | 1,98 | 1,99 | 1,96 | 1,98 | +1,01% | 1,34% | 5.519.606 |
| 22/03/1982 | 1,95 | 1,97 | 1,93 | 1,96 | +1,54% | 2,21% | 5.006.506 |
| 19/03/1982 | 1,94 | 1,95 | 1,93 | 1,93 | -1,19% | 1,19% | 3.387.974 |